Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate. The results of this trial in Asia (involving Sanofi Pasteur’s dengue vaccine candidate) were published this summer, July 11, in The Lancet.
Here in the second day of the WHO/AFRO Annual Regional Conference on Immunization in Ouagadougou, Burkina Faso, participants heard how the Democratic Republic of Congo and Cameroon are working together to develop sustainable immunization financing plans.
On December 6-9, 2010, the WHO will host ARCI/ARICC meetings in Ouagadougou, Burkina Faso. The Sustainable Immunization Financing (SIF) Program at Sabin will host and oversee a Parallel 3 Session dedicated to Immunization Financing.
On September 8, 2010, Parliamentarians met with Senior Program Officer Diana Kizza to discuss Sustainable Immunization Financing. Attending, were: Hon Dr. Robert Monda (Chair Health Committee), MP; Hon Dr Eseli Simiyu, MP; Hon Dr. Bori Khalwale MP; Hon Dr.